Cancer Cure

The Indian Cancer Society-Cancer Cure Fund is a flagship project which provides financial aid for treatment to underprivileged cancer patients. Many cancers are treatable, if detected early and treated in time. However, many cancer patients in India are not able to afford the treatment costs and therefore do not survive the disease. This project has transformed the lives of over 8100 patients across the country, many of whom have completed their treatment and returned to a productive life once again. This program is implemented at a pan India level and we are pleased to report that 45% of the beneficiaries are between 16-45 yrs. of age.

This project is a unique, first of its kind initiative in collaboration with HDFC AMC Ltd. In February 2011, HDFC AMC launched a Debt Mutual fund which gave the investors an option to donate 50% or 100% of their dividend income to Indian Cancer Society to fund the treatment cost for cancer patients. ICS is grateful to each of the 5000 investors who have donated their income to the Cancer Cure Fund. ICS appreciates the continued support of HDFC AMC which has helped save thousands of precious lives.

Amount sanctioned till 31st March 2021 is Rs. 215.52 Cr. for 9742 patients and Net disbursed is Rs. 153.71 Cr.

Patient's eligibility criteria:
  • Family income should not exceed Rs 4 lakh per year
  • Patient should be treated at ICS empanelled hospital only.
  • Patients should be registered under general category
  • Projected survival rate 50% for adult patients and 70% for pediatric patients
  • Only for Indian citizens
Sanction criteria:
  • Minimum sanction Rs 50,000 to maximum Rs 5 lakhs
Treatment protocol covered:
  • Chemotherapy
  • Radiation
  • Surgery
  • Supportive care
  • Prosthesis
  • Nutrition
  • HDFC AMC Ltd
  • Bharat Petroleum Energising Lives

Why Indian Cancer Society is the best NGO funding cancer treatment today.
Celebrating CCFs 200th meeting of the Governing Advisory Council(GAC)

Our Stakeholders Speak

  • Dr S Banavali

    With the newer modalities of treatment, the outcome of many non-metastatic cancers has now improved and we can expect more than half of these patients to survive. However, this improved outcome comes at a cost which is beyond the reach of many patients in India. Because of timely help from ICS CCF, thousands of patients across India could undergo treatment with dignity and are now cured of their disease. Thank you, ICS, for making this possible.

    Dr S Banavali, MD, Director, Academics & Prof, Head Medical Oncology - Tata Memorial Centre, Mumbai

  • Dr Tushar Vora

    The evolution of CCF into a sustainable and successful source of financial help for cancer patients from all over the country is exemplary. The partnership between the treating hospitals and the funding sources works on the principles of trust and due diligence. With the potential of a tremendous impact on the healthcare sector of India, consolidation and expansion of the scheme is extremely essential.

    Dr Tushar Vora, MD (Pediatrics), Prof Medical Oncology, Tata Memorial Centre, Mumbai

  • Dr Ravi Kannan

    It is a pleasure to work with ICS CC. In a remote place like Cachar, our efforts to treat cancer patients is made worth the while on account of the support we get from ICS. The team at ICS is committed and makes us feel part of a much larger mission. They often nudge us to apply for more patients, submit reports on time, submit our claims and utilisation reports on time....all without any harassment or offence....purely to ensure that help reaches as many patients as possible. Cachar Hospital, Assam along wtih ICS has supported around 155 cancer patients so far.

    Dr Ravi Kannan, Director Cachar Cancer Hospital and Research Centre, Assam

  • Dr Sunil Khetrapal

    Our hospital has been associated with ICS CCF for the last five years. This is a very useful scheme in favour of underprivileged patients (particularly pediatrics) undergoing treatment for various types of cancers.

    We have been working jointly with ICS to be able to support about 150 children with cancer and many of these patients have completed their treatment and are leading normal lives. The sympathetic help by ICS for needy cancer patients is noteworthy and is much appreciated by us.

    Dr Sunil Khetrapal, COO & MS Rajiv Gandhi Cancer Institute New Delhi

  • Dr. Devi Shetty

    I am very excited to work with Indian Cancer Society to scale up the operations and reach out to millions of deserving patients. We have to look at how to downstage cancer by detecting it early using technology. Technology is the best way to reduce the cost and reach out to millions. Look forward to work with you and make this world a better place to live in."

    Dr. Devi Shetty, Chairman and Founder Mazumdar Shaw Cancer Centre - Bangalore

  • Dr. V.Shanta

    Cancer Institute (W.I.A) Chennai, is privileged to be associated with Indian Cancer Society (ICS). Over the last 6 decades we have strived hard to provide the state of art treatment to the underprivileged without any social or economic divide. This has been made easier by the generosity of ICS whose funding has helped us to fulfill the needs of many patients. Over the last 3 years, the financial assistance from ICS is Rs.2.7 Crores which has supported 120 patients. This funding has been used for providing bone marrow transplantation, limb salvage surgery, many major surgeries, radiotherapy and chemotherapy.

    The unique feature of the funding from ICS is the promptness with which the funds are released. This has helped us in treating patients without delay. We are proud to say that we have not refused “state of art treatment” to any of the patients who have come seeking help.

    Dr. V.Shanta, Chairman Cancer Institute, Adyar

  • Dr. Raju Titus Chacko

    The Christian Medical College, Vellore has been striving to provide excellent, affordable care to patients who come from all over the country. Patients who come from the poorer and vulnerable strata of society are preferentially afforded the best possible treatment. Partnering with the Indian Cancer Society in providing funding for curable cancers has tremendously increased the number of such patients receiving treatment. They go home with a satisfied smile and much gratitude, knowing that they have beaten the dreaded disease and have been looked after in the best way possible. Thank you ICS and all your donor funding partners for boosting our ability to deliver such treatments.

    Dr. Raju Titus Chacko, Professor Medical Oncology, Christian Medical College, Vellore

  • Dr (Prof) R A Badwe

    Indian Cancer Society’s Cancer Cure Fund is one of the most innovative ideas to help & support cancer patients in India. It will not be an exaggeration, if I say this is quite innovative globally, that investors would put in funds and this fund will be utilized for poor patients and they would get some tax benefits out of that. What is unique about this fund is that it has a shortest turnaround time. Unless the funds are available the treatment cannot begin and these funds are immediately made available by Indian Cancer Society’s Cancer Cure Fund. This has reduced abandonment of treatment by more than 50% of patients.

    Dr (Prof) R A Badwe (Hospital Partner) Director, Tata Memorial Hospital, Mumbai

  • Mrs. Daya N Pal

    Sri Shankara Cancer Hospital, Bengaluru is committed to serve the under-privileged cancer patients. Indian Cancer Society has stood by our organization in fulfilling our objectives. During the last 5 years, 200 patients received generous support from ICS Cancer Cure Fund. Sri Shankara Cancer Foundation is grateful to ICS, in ameliorating the suffering of these patients, and hope that ICS will strengthen our efforts by their unstinted and continued support. I personally feel very blessed to be associated with SSCF and ICS, both of who are doing such exemplary service for mankind.

    Mrs. Daya N Pal Core-Committee Member, SSCHRC and Co-ordinator for ICS - CCF

Empanelled Hospitals

Empanelment Yr. Hospital Name State / U.T. Address Telephones
  • Tata Memorial Hospital
Maharashtra Parel, Mumbai, Maharashtra - 400 012 022-24177000
  • Regional Cancer Centre
Kerala Medical College Campus,
Post. Bag No: 2417,
Thiruvananthapurambr, Kerala - 695 011
0471 244 2541
  • Christian Medical College (CMC)
Tamil Nadu Vellore
Tamil Nadu - 632 004
0416 2283350 / 5213350
  • Cancer Institute (CI)
Tamil Nadu Adyar, Chennai,
Tamil Nadu - 600 020
044 24911526
  • GCRI - Gujarat Cancer Research Institute
Gujarat Civil Campus, Asawra,
Ahmedabad, Gujarat - 380 016
079 2268 8000
  • Rajiv Gandhi Cancer Institute & Research Center
Delhi Sector 5, Rohini,
Delhi - 110 085
011 4582 2222
  • Sher i Kashmir Institute of Medical Sciences
J &K Post Bag No. 27,
Soura, Srinagar,
Jammu & Kashmir - 190 011
0194 240 1013
  • BKL Walawalkar Hospital
Maharashtra Shreekshetra Dervan,
Chiplun, Ratnagiri,
Maharashtra - 415 606
02355-264137 / 264149
  • Basavatarakam Indo American Cancer Hospital
Telangana Road No 10, Banjara Hills,
Telangana 500 034
040 2355 1235
  • Kailash Cancer Hospital
Gujarat Muni Seva Ashram, 12-Blue Chip Complex,
Near Rajshree Cinema, Opp Vakal Seva Kendra,
Sayajigunj, Vadodara, Gujarat - 391 760
02668 265 300
  • Patel Hospital
Punjab Civil Lines,
Jalandar, Punjab - 144 001
0181-2041000 / 3041000
  • Mahavir Cancer Sanstha and Research Center
Bihar Phulwarisharif,
Patna - 801 505
0612 - 2250127, 7091490890
  • Cachar Cancer Hospital & Research Center
Assam Meherpur,
Assam, Silchar - 788 015
  • Sri Shankara Cancer Hospital & Research Center
Karnataka 1st Cross, Shankara Matt Premises,
Shankarapuram, Basavanagudi,
Bengaluru, Karnataka - 560 004
080 2698 1000
  • Padhar Hospital
Madhya Pradesh Padhar Hospital, Post - Padhar, Dist - Betul, Madhya Pradesh - 460 001 91-714-126-3228
  • Homi Bhabha Cancer Hospital
Uttar Pradesh Ghanti Mill Rd, Lahartara Boulia, Old Loco Colony, Shivpurwa, Varanasi, Uttar Pradesh-221 002 0685 - 2413546
  • Mahamana Pandit Madan Mohan Malaviya Cancer Centre
Varanasi, Uttar Pradesh BHU Campus, Naria Rd, Sundar Bagiya Colony, Varanasi, Uttar Pradesh - 221 005 +91-0542 2575032
Due Diligence Team (DDT)

Mumbai & Navi Mumbai

  • Dr. Nehal Khanna
    Dr. Nehal Khanna, Chairperson
  • Dr. Tushar Vora
    Dr. Tushar Vora
  • Dr. Anant Gokarn
    Dr. Anant Gokarn
  • Dr. Manish Bhandare
    Dr. Manish Bhandare
  • Dr. Shraddha Patkar
    Dr. Shraddha Patkar
  • Dr. Sachin Punatar
    Dr. Sachin Punatar


  • Dr. Hari Menon
    Dr. Hari Menon, Chairman
  • Dr. Kumaraswamy
    Dr. Kumaraswamy
  • Dr. Ravi Thippeswamy
    Dr. Ravi Thippeswamy
  • Dr. Shekhar Patil
    Dr. Shekhar Patil
  • Dr. Vikram Kekatpure
    Dr. Vikram Kekatpure
Governing Advisory Council (GAC)
  • Mrs. Usha Thorat
    Mrs. Usha Thorat, Chairperson
  • Mr. M K Sharma
    Mr. M K Sharma
  • Mr. Navneet Munot
    Mr. Navneet Munot
  • Mr. Naveen Kshatriya
    Mr. Naveen Kshatriya
  • Mr. Hari L Mundra
    Mr. Hari L Mundra
  • Dr. Anita Borges
    Dr. Anita Borges
  • Mr. Ramesh Swaminathan
    Mr. Ramesh Swaminathan
  • Dr. Purna Kurkure
    Dr. Purna Kurkure
  • Mr. Kewal Nohria
    Mr. Kewal Nohria
  • Mr. Gautam Chakravarti
    Mr. Gautam Chakravarti
  • Mrs. Jyotsna Govil
    Mrs. Jyotsna Govil
  • Mr. Kishore Rao
    Mr. Kishore Rao
  • Dr. Shailesh Ayyangar
    Dr. Shailesh Ayyangar
  • Dr. Manju Senger
    Dr. Manju Senger
  • Dr. Nilesh Lokeshwar
    Dr. Nilesh Lokeshwar

Arun Kurkure Initiation & Treatment Fund


This project was launched in April 2014 in Mumbai to support underprivileged cancer patients towards initial diagnostic tests and funding for emergency treatment, without any loss of time.

Many patients come to a cancer hospital, but are unable to do the diagnostic tests due to lack of funds. They go back home and return to the hospital when the cancer is in an advanced stage, making treatment difficult.

This immediate assistance is a big help to patients, it reduces the drop rate of patients and allows them to start treatment giving them time to look for other sources of assistance.

The Project was re-launched on 4th Feb 2019 at our empanelled hospitals -

  • Padhar Hospital, Betul, Madhya Pradesh
  • Sher i Kashmir Institute of Medical Sciences, Srinagar, J&K
  • NH SRCC Children's Hospital, Mumbai, Maharashtra
  • Cachar Cancer Hospital and Research Centre, Silchar, Assam
  • BKL Walawalkar Hospital, Chiplun, Maharashtra
Padhar Hospital, Betul, Madhya Pradesh
Sher i Kashmir Institute of Medical Sciences, Srinagar, J&K
NH SRCC Children's Hospital, Mumbai, Maharashtra
Cachar Cancer Hospital and Research Centre, Silchar, Assam
BKL Walawalkar Hospital, Chiplun, Maharashtra
Homi Bhaba Cancer Hospital
Mahamana Pandit Madan Mohan Malaviya Cancer Centre

 AKITF Inauguration

Maximum of Rs 25,000 - per patient is sanctioned for initial diagnosis & initial treatment

Amount disbursed till 31st March 2021 is Rs. 2.14 Cr. for 1252 patients

Patient eligibility criteria
  • Only for Indian citizens
  • No discrimination on account of age, sex or religion
  • The patient must be registered as a general ward patient
  • Family income not exceeding Rs 4 lakhs per annum
  • Initial treatment will be applicable only for cancer diagnosed patients

Documentation from patient
  • Aadhar card of the patient (if pediatric patient, then Aadhar card of the one of the parents)
  • Income proof that patient’s family income is not exceeding Rs 4 lakhs per annum
  • Registration page confirming patient belonging to general category of the empanelled hospital
  • Prescription of the treating doctor for initial diagnosis
  • Cost certificate for initial treatment from the treating doctor
  • Additional documents for initial treatment: All cancer reviewed and attached to the documentation by the hospital
  • Photo of the patient

Contact Us

Ann Rawat, Director - Cancer Cure
Tel : +91-22-2412 1682